Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia
| Image |  |
|---|---|
| Description | scientific article published on September 23, 2011 |
| Author/s |
author: David Rizzieri J Brice Weinberg |
| Publication date | September 23, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.610012 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |